Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jealsa is a prominent Spanish corporation that has integrated advanced marine biotechnology into its core seafood processing operations through its Valora division. The company operates a sophisticated circular economy model, transforming tuna by-products into high-value bioactive ingredients for the pharmaceutical, nutraceutical, and cosmetic industries. Its primary life science offerings include pharmaceutical-grade docosahexaenoic acid, eicosapentaenoic acid, collagen, and chondroitin sulfate. Jealsa's manufacturing capabilities are centered around its biorefinery in Spain, which ensures full traceability and sustainability of its marine-derived products. By bridging the gap between food processing and biotechnology, Jealsa provides essential raw materials for global health applications. The company remains a private, family-owned entity with a significant international footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jealsa.